# Newronika S.p.A.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/newronika-s-p-a

- Industry: Medical Devices & Equipment
- Headquarters: Milan, Italy
- Website: www.newronika.it
- Total disclosed funding: $25M
- Latest round: Series B (Feb 13, 2025)
- Investors on record: 8

## About

Established in 2016 and based in Milan, Italy, Newronika S.p.A. operates as a developer of AlphaDBS, an implantable device that stimulates the brain for patients affected by Parkinson's disease. The company also offers WebBioBank, an online platform used by healthcare professionals in diagnosing and analyzing biosignals. The platform also enables patients to connect with WebBioBank.

## Funding rounds

- Series B, Feb 13, 2025, $14M — Innogest, F3F S.p.A., Indaco Venture Partners, Wille Finance, Fondazione ENEA Tech e Biomedical, TNBT Capital
- Series A, Sep 25, 2019, $9.2M — Omnes Capital, Innogest, Intesa Sanpaolo, F3F S.p.A., Indaco Venture Partners
- Series A, Jun 14, 2016, $1.9M — Intesa Sanpaolo, Innogest, F3F S.p.A.

## Investors

- Intesa Sanpaolo — Series A
- Innogest (https://capitalatlas.ai/funds/innogest) — Series A, Series B
- F3F S.p.A. — Series A, Series B
- Omnes Capital (https://capitalatlas.ai/funds/omnes-capital) — Series A
- Indaco Venture Partners (https://capitalatlas.ai/funds/indaco-venture-partners) — Series A, Series B
- Wille Finance — Series B
- Fondazione ENEA Tech e Biomedical — Series B
- TNBT Capital (https://capitalatlas.ai/funds/tnbt-capital) — Series B